Statera BioPharma (STAB) Q2 2021 Earnings Report
STAB Q2 2021 EPS Results
- Actual EPS
- -$0.04
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.03
STAB Q2 2021 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/16/2021
- Time
- Before Open
- Conference Call
- Monday, August 16, 2021
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
STAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 14, 2023 | 2023 (Q2) | ―- | ― | ― | |
| Nov 14, 2022 | 2022 (Q3) | ―-0.07 | -0.47 | 85.74% (+0.40) | |
| Aug 15, 2022 | 2022 (Q2) | ―- | -0.04 | ― | |
| Nov 15, 2021 | 2021 (Q3) | ―-0.47 | -0.06 | -724.56% (-0.41) | |
| Aug 16, 2021 | 2021 (Q2) | ―-0.04 | -0.03 | -38.71% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed